Afya (NASDAQ:AFYA) Insider Sells $52,867.50 in Stock

20 Apr 2026, 13:22 by Scott Moore · The Cerbat Gem

Afya Limited (NASDAQ:AFYA – Get Free Report) insider Santos Welder Ferreira sold 3,325 shares of the company’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $15.90, for a total transaction of $52,867.50. Following the transaction, the insider owned 35,000 shares of the company’s stock, valued at approximately $556,500. This trade represents a 8.68% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Afya Price Performance

Shares of AFYA traded up $0.18 during mid-day trading on Monday, hitting $16.04. 21,796 shares of the company were exchanged, compared to its average volume of 114,044. Afya Limited has a 1-year low of $13.00 and a 1-year high of $19.90. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.20 and a current ratio of 2.20. The company has a 50 day moving average of $14.54 and a 200-day moving average of $14.67. The stock has a market cap of $1.50 billion, a price-to-earnings ratio of 10.98, a price-to-earnings-growth ratio of 0.71 and a beta of 0.48.

Afya (NASDAQ:AFYA – Get Free Report) last released its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The firm had revenue of $147.08 million during the quarter, compared to the consensus estimate of $174.74 million. Analysts expect that Afya Limited will post 1.52 EPS for the current fiscal year.

Afya Dividend Announcement

The firm also recently disclosed an annual dividend, which was paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th were issued a $0.656 dividend. The ex-dividend date was Wednesday, March 25th. This represents a yield of 433.0%. Afya’s dividend payout ratio is presently 45.21%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on AFYA shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a report on Wednesday, January 21st. Wall Street Zen upgraded shares of Afya from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 14th. Bank of America downgraded shares of Afya from a “buy” rating to a “neutral” rating and cut their price objective for the company from $22.00 to $17.00 in a report on Tuesday, February 24th. Zacks Research upgraded shares of Afya from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 7th. Finally, Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a report on Friday, January 16th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $17.30.

Read Our Latest Research Report on AFYA

Institutional Trading of Afya

Hedge funds and other institutional investors have recently made changes to their positions in the company. Daiwa Securities Group Inc. purchased a new position in shares of Afya during the 4th quarter worth approximately $43,000. Militia Capital Partners LP purchased a new position in shares of Afya during the 2nd quarter worth approximately $71,000. Quantbot Technologies LP purchased a new position in shares of Afya during the 2nd quarter worth approximately $117,000. State of Wyoming purchased a new position in shares of Afya during the 2nd quarter worth approximately $164,000. Finally, Van ECK Associates Corp boosted its position in shares of Afya by 15.7% during the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after purchasing an additional 1,377 shares during the period. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.